Discovery of direct inhibitor of KRAS oncogenic protein by natural products: a combination of pharmacophore search, molecular docking, and molecular dynamic studies

BACKGROUND AND PURPOSE: Aberrant signaling by oncogenic RAS proteins occurs in almost all human tumors. One of the promising strategies to overcome such cancers is the inhibition of KRAS protein, a subtype of RAS family involved in cell growth, differentiation, and apoptosis, through preventing its...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemi, Samaneh, Sharifi, Amirhossein, Zareei, Sara, Mohamedi, Ghazale, Biglar, Mahmood, Amanlou, Massoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540812/
https://www.ncbi.nlm.nih.gov/pubmed/33088323
http://dx.doi.org/10.4103/1735-5362.288425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540812/
https://www.ncbi.nlm.nih.gov/pubmed/33088323
http://dx.doi.org/10.4103/1735-5362.288425

Ejemplares similares